The Trump administration this week decimated HIV prevention programs across government health agencies after terminating ...

In part 1 of this interview with Katrina Ortblad, ScD, MPH, she addressed bridging gaps in HIV care with pharmacy-based ...

PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...

Scientists from the University of KwaZulu-Natal conducted a test trial on a group of women from Umlazi to determine the ...

First Nations and Inuit are now covered to receive the HIV prevention drug Apretude, which is 99 per cent effective according ...

Zimbabwe is one of the countries in the region that has managed to reach the 95-95-95 targets, which has brought epidemic ...

Diagnosed as HIV positive over 30 years ago, the 65-year-old president of KLASS is on a mission to help break the chain of infection.

Overview of HIV Drugs MarketThe Global HIV Drugs Market is valued at USD 34.75 Billion in 2024 and is projected to reach a ...

The recent US funding cuts have created critical gaps in the HIV response across East and Southern Africa. The gaps, unless filled, will have severe public health consequences, reversing the gains ...

(Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company focused on immunology and inflammation, today announced in addition to developing TH104 for the proposed ...

Sens. Bill Cassidy, MD (R-La.), and Bernie Sanders (I-Vt.) asked HHS Secretary Robert F. Kennedy Jr. to testify before the ...